This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Assistance Publique - Hopitaux De Paris (Aphp), Centre National De La Recherche Scientifique, Cornell University. Active years: 2015-2019.
Company Filing History:
2 out of 77 
2 out of 5,383 
2 out of 2,948 
Years Active: 2015-2019
Title: Pierre Bougneres: Innovator in Cardiomyopathy Research
Introduction: Pierre Bougneres, an accomplished inventor based in Le Kremlin Bicetre, France, holds an impressive portfolio of two patents that focus on the treatment and prevention of cardiomyopathy associated with Friedreich ataxia. His innovative approaches have the potential to significantly impact the medical field and improve the lives of those affected by this condition.
Latest Patents: Bougneres' latest patents detail sophisticated methods and pharmaceutical compositions aimed at combating cardiomyopathy due to energy failure. The patents offer a therapeutic avenue by administering a vector containing a nucleic acid sequence that encodes a gene capable of reversing energy failure. This revolutionary method specifically targets cardiomyopathy related to Friedreich ataxia, utilizing the frataxin (FXN) nucleic acid sequence as a key component in its approach.
Career Highlights: Pierre Bougneres has made significant contributions to medical research through his affiliations with reputable institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work has positioned him as a prominent figure in the fields of genetics and cardiology, with a special focus on genetic disorders.
Collaborations: Throughout his career, Bougneres has collaborated with esteemed colleagues, including Helene Monique Puccio and Patrick Aubourg. These partnerships underscore the importance of teamwork and collective expertise in pushing the boundaries of medical research and innovation.
Conclusion: Pierre Bougneres is a notable inventor whose work on cardiomyopathy treatments showcases the essential role of innovation in addressing complex medical issues. His dedication to research and collaboration exemplifies the spirit of scientific inquiry, with the potential to bring forth effective solutions for patients suffering from Friedreich ataxia. As his work continues to evolve, the medical community eagerly anticipates the positive impact of his discoveries.